Stay updated on Nivolumab with Bevacizumab in Glioblastoma Clinical Trial
Sign up to get notified when there's something new on the Nivolumab with Bevacizumab in Glioblastoma Clinical Trial page.

Latest updates to the Nivolumab with Bevacizumab in Glioblastoma Clinical Trial page
- Check3 days agoNo Change Detected
- Check11 days agoChange DetectedAdded Revision: v3.5.0 and removed Revision: v3.4.3 from the revision history.SummaryDifference0.1%

- Check18 days agoChange DetectedRevision tag updated to v3.4.3. The previous v3.4.2 tag was removed.SummaryDifference0.1%

- Check25 days agoNo Change Detected
- Check46 days agoChange DetectedAdded Revision: v3.4.2; Deleted older notice about funding/operation status (Revision: v3.4.1). These are administrative updates that do not affect trial content or how users interact with the page; To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.4%

- Check53 days agoChange DetectedAdded a site-wide notice about a lapse in government funding and the NIH Clinical Center's operating status, and updated the page revision to v3.4.1 (replacing v3.4.0). To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.4%

- Check61 days agoChange DetectedThese are minor UI/metadata updates: a glossary toggle was added, and labels such as 'Last Update Submitted that Met QC Criteria' and 'Revision: v3.4.0' appeared, while the older 'Last Update Submitted that met QC Criteria', 'No FEAR Act data', and 'Revision: v3.3.4' were removed. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.2%

- Check75 days agoChange DetectedMinor metadata update: the footer now shows Revision: v3.3.4, replacing Revision: v3.3.3. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.1%

Stay in the know with updates to Nivolumab with Bevacizumab in Glioblastoma Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Nivolumab with Bevacizumab in Glioblastoma Clinical Trial page.